Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study

The aim of the study was to evaluate efficacy and tolerance of epirubicin and gemcitabine as first-line chemotherapy in patients with advanced non-small-cell lung cancer. A phase I study was performed with the combination of escalating doses of epirubicin intravenously on day 1 and a fixed dose of g...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: van Putten, J W G, Eppinga, P, Erjavec, Z, de Leede, G, Nabers, J, Smeets, J B E, Sleijfer, D Th, Groen, H J M
Формат: Статья
Язык:English
Опубликовано: Nature Publishing Group 2000
Предметы:
Regular Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374380/
https://ncbi.nlm.nih.gov/pubmed/10732750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.1003
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2374380/
https://ncbi.nlm.nih.gov/pubmed/10732750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.1003

Схожие документы